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Abstract
Constipation is a common gastrointestinal (GI) disorder among all age groups.
Constipation can be functional or pathological comprising of many etiologies. It can
also be classified as acute or chronic; mild to severe. Although in most of the cases it
is benign, symptoms can significantly affect the quality of life and cost-related
burden for the patient. However, chances of late diagnosis of constipation are high
due to a variety of etiologies and variable presentation. Most of the times, it is a
great challenge for the clinician to find out the cause of constipation. Healthy
lifestyle, especially keeping regular bowel habit, drinking adequate fluid, and the
use of high-fiber diet that reduces the viscosity of stool, minimizes intestinal transit
time and decreases the chance of constipation. Early diagnosis and management of
other underlying factors are important to give relief to the patient from the undue
physical and psychological stress.
Keywords: constipation, gastrointestinal disorder, clinical approach, diagnosis,
management
1. Introduction
Constipation is a vague term. There is no single definition of it. Constipation is
mostly defined by one or more of following symptoms: passage of hard-formed
stools or less and dry bowel movements (typically less than three per week), exces-
sive straining, a sense of incomplete bowel evacuation, and excessive time spent on
the toilet or in unsuccessful defecation. Nevertheless, even those with regular bowel
habits might experience constipation [1, 2]. Similarly, definition of constipation has
also been devised according to Rome Criteria (Table 1).
Many factors seem to play roles in the causation which when taken care of
timely and wisely can create a huge difference. Besides the medical and surgical
causes which are mostly unavoidable, food habits and other personal habits are
within everyone’s control. Healthy lifestyle, consumption of high fiber diet,
maintaining adequate hydration and regular bowel habits, careful use of laxatives,
and control of medications minimize the problems of constipation.
2. Epidemiology
Constipation is a common condition all around the globe. Worldwide prevalence
rates range from 0.7 to 79% with an overall median of 16% and a median of 33.5%
among older population [5]. Different surveys have reported the prevalence
between 1% and more than 20% in Western populations which can be attributed to
different factors [6]. Constipation has been found more prevalent in women than in
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men, in nonwhites than in white persons, in children than in adults, and in elderly
than in younger adults. According to the 1996 National Health Interview Survey,
about 3 million people in the United States are found to have frequent constipation.
Likewise more than 2.5 million visit to physicians, 92,000 hospitalizations, and
laxative sales of several hundred million dollars a year in US [7–9]. It has also been
stated as a common problem during pregnancy and childbirth [1] According to a
study by Jewell DJ and Young G, the prevalence of constipation was estimated to
affect 11–38% of pregnancies [10]. To be more specific, constipation is an extremely
common disorder in childhood. Up to 25% of all pediatric gastroenterological con-
sultations and 3% of all pediatric outpatient visits are due to constipation. The
prevalence of functional constipation at pediatric gastroenterology clinics in sec-
ondary or tertiary care hospitals ranged from 1.8 to 13.9% [11]. Studies have shown
that 0.7 to 29.6% of children are constipated worldwide. Similarly, 3–5% of pediatric
primary care visits and up to 25% of gastroenterology consultations are accounted to
constipation. Nearly all childhood constipation is functional, but 5–10% is due to an
organic cause [12–16].
Sixty percent of women were found to have constipation at least weekly and
more than 90% monthly in a study from Canada. Men had less frequency of
constipation and GI symptoms than women. These symptoms were present for
more than 10 years in around 60% of women [17]. In the same manner, the
prevalence of self-reported constipation was 21% in community-dwelling adults in
Australia. The prevalence in Norwegian nursing homes was 23.4%, and 67% while it
was found in 50% of institutionalized elderly in a Swedish study. Prevalence in
nursing homes in Ireland was 38% [18]. In a study in US elderly above 65 years that
reported being constipated, persistent straining was reported by 65%. A study from
Finland revealed that 57% of women and 64% of men reported chronic constipation
Rome II criteria Rome III for pediatric age group
Adults
Two or more of the following for at least 12 weeks
(not necessarily consecutive) in the preceding
12 months:
• Lumpy or hard stools for >25% of bowel
movements
• Sensation of anorectal blockage for >25% of
bowel movements
• Straining during >25% of bowel
movements
• Sensation of incomplete evacuation for
>25% of bowel movements
• Manual maneuvers to facilitate >25% of
bowel movements (e.g., digital evacuation
or support of the pelvic floor)
• Loose stools not present and insufficient
criteria for irritable bowel syndrome
• Less than three bowel movements per week
Infants and children
• Pebble-like, hard stools for a majority of
bowel movements for at least 2 weeks
• Firm stools ≤ 2 times per week for at least
2 weeks
• No evidence of structural, endocrine, or
metabolic disease
Child with developmental age < 4 years:
• Less or equal to two defecations per week
• At least one incontinence per week after the
acquisition of toileting skills
• History of painful or hard bowel movements
• History of excessive stool retention
• History of large-diameter stools that may
obstruct the toilet
• Presence of a large fecal mass in the rectum
• Additional symptoms may include
irritability, decreased appetite, and/or early
satiety, which may resolve immediately after
defecation of a large stool
Child with developmental age ≥ 4 years:
• ≤ 2 defecations in the toilet per week
• At least one episode of fecal incontinence
per week
• History of retentive posturing or excessive
volitional stool retention
• History of painful or hard bowel movements
• Presence of a large fecal mass in the rectum
• History of large-diameter stools that may
obstruct the toilet
Table 1.
Rome II criteria [3] and Rome III for pediatric age group [4].
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prevalence increased to 79 and 81%, respectively, in a nursing home setting [19–23].
The burden of constipation reflects on work productivity. According to a study by
Hunt et al., almost 30% believe that they were less productive at work or at school,
13% missed work or school days, and nearly 10% were late or had to leave work or
school because of their symptoms [19].
3. Etiopathogenesis
Constipation is multifactorial most of the times. It can be classified into three
broad categories: Normal-transit constipation, slow-transit constipation, and
defecatory disorders. In a study of more than 1000 patients with chronic constipa-
tion by Mugie Benninga and Di Lorenzo in 2011, normal transit was the most
prevalent form (59%) followed by defecatory disorders (25%) and slow transit
(13%) and a combination of defecatory disorders and slow transit (3%).
More than one mechanism may contribute to constipation in a patient [5, 24].
Normal-transit constipation is likely due to a perceived difficulty with evacuation or
presence of hard stools. Stool traverses at a normal rate in the colon and is respon-
sive to dietary modification alone medications [25]. Dysfunction of the pelvic floor
or anal sphincter commonly leads to defecatory disorders. Failure of the rectum to
empty effectively may be due to an inability to coordinate the abdominal, rectoanal,
and pelvic floor muscles during defecation [26, 27].
Slow-transit constipation occurs most commonly in young women with infre-
quent bowel movement which occurs by colonic inertia and colonic overactivity
mainly due to decreased colonic activity and increased, uncoordinated colon activity.
Evacuation disorder is another subtype that occurs due to normal or prolonged
colonic transit, but evacuating stools from the rectum are inadequate/difficult [6].
Associated symptoms are an infrequent urge to defecate, bloating, and abdominal
pain or discomfort. Symptoms of constipation typically respond to therapy with
dietary fiber alone or with the addition of an osmotic laxative [28]. There are a
number of factors leading to the above condition that have been listed below [20, 29].
3.1 Causal factors
• Surgical conditions: colorectal tumor and compression form external tumor,
diverticulosis, anal fissure, strictures, megacolon, and postsurgical
abnormalities
• Metabolic diseases: diabetes mellitus, hypercalcemia, hypokalemia,
hypomagnesemia, hypermagnesemia, hyperparathyroidism, hypothyroidism,
chronic kidney disease, dehydration, heavy metal poisoning, multiple
endocrine neoplasias II, and porphyria
• Gastrointestinal conditions: abscess, anal fissure, fistula irritable bowel
syndrome, hemorrhoid, levator ani syndrome, megacolon, proctalgia fugax,
rectal prolapse, rectocele, and volvulus
• Musculoskeletal disorder: scleroderma, systemic sclerosis, amyloidosis, and
dermatomyositis
• Dietary: eating disorders, dehydration, and low fiber
• Depression and dementia
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• Medications
• Others: degenerative joint disease, immobility, cardiac disease, pregnancy, and
urinary incontinence
4. Specific associations
4.1 Constipation in children
Children presenting to the emergency department with abdominal pain are most
often diagnosed with constipation. Different studies have reported behavior prob-
lems higher among children with constipation. Fecal incontinence is a mental dis-
order that requires psychiatric treatment [30–33]. Other studies, however, have
shown that there is a strong association between successful treatment and the
reduction of behavior problems suggesting that behavior problems are secondary to
the clinical symptoms of constipation [34–36].
4.2 Constipation and morphine
In a study by Joanne Droney et al. in 2007 in cancer patients in morphine, 72% of
the patients were found to have mild to severe constipation. Among 53% out of
those who were not constipated, 47% were taking laxatives on and off. Of those
who said that they were constipated, 73% were already on laxatives, but 27% were
not taking any laxatives [37]. Constipation in hospice patients occurs in the major-
ity. About 70–87% opioids account for only 25% of constipation in hospice patients.
Persistent constipation correlates with a reduced performance status and not mor-
phine dose. A subgroup of individuals did not require laxatives despite being on
higher doses of morphine [38, 39].
4.3 Enuresis association
Yanli Ma et al. in a study from 2016 to 2017 found a positive correlation between
constipation (Rome III scores) and frequency of micturition. They also found that
constipated children had a higher incidence of severe enuresis and lower incidence
of mild-moderate enuresis (68.7 versus 44.6% and 31.3 versus 55.4%) [40].
4.4 Pregnancy and constipation
Hormonal changes during pregnancy, more specifically progesterone rise and
serotonin, are responsible for reduced intestinal smooth muscle motility via inhibi-
tion of motilin, a smooth muscle stimulant. Similarly relaxin acts on the
myometrium and contributes to intestinal gut hypomotility. Another important
factor is increased sodium and water reabsorption due to increased aldosterone as a
result of increased estrogen and progesterone. This results in hardening of stools
[41]. Pregnant women were found to be most prone to developing constipation in
the first two trimesters according to a study. In the first and second trimesters, the
prevalence of functional constipation ranges between 35 and 39%. Similarly, it is 21
and 17% in the third trimester and puerperium, respectively. Adequate hydration
and dietary fiber with or without laxatives are the first line of management. In case
of severe or refractory cases, referral is mandatory for further management [42].
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4.5 Constipation in elderly
Constipation is more frequent among elderly residents of long-term care facilities
revealed by a study from the United States in persons older than 65 years. There are
intrinsic changes, reducednumber of neurons inmyenteric plexus, and reduction in the
amplitude of inhibitory nerve input to circular muscle layer of colon causing constipa-
tion in the elderly that has been found in the study of colonic physiology [43, 44].
Class examples Examples
5-HT3 receptor antagonists
Analgesics
Opiates
Nonsteroidal anti-inflammatory agents
Anticholinergic agents
Tricyclic antidepressants
Antiparkinsonian drugs
Antipsychotics
Antispasmodics
Antihistamine
Anticonvulsants
Antihypertensives
Calcium channel blockers
Diuretics
Centrally acting
Antiarrhythmics
Beta-adrenoceptor antagonist
Bile acid sequestrants
Cation-containing agents
Iron supplements
Lithium
Chemotherapy agents
Vinca alkaloids
Alkylating agents
Miscellaneous compounds
Endocrine Medications
Other antidepressants
Other antipsychotics
Other antiparkinsonian drugs
Other antispasmodics
Sympathomimetics
Ondansetron
Morphine
Ibuprofen
Belladonna
Amitriptyline, nortriptyline
Benztropine
Chlorpromazine
Dicyclomine
Diphenhydramine
Carbamazepine
Verapamil, nifedipine
Furosemide
Clonidine
Amiodarone
Atenolol
Cholestyramine, Colestipol
Aluminum Antacids, Sucralfate
Ferrous sulfate
Vincristine
Cyclophosphamide
Barium sulfate, Oral contraceptives, Polystyrene resins
Pamidronateand alendronic acid
Monoamine oxidase inhibitors
Clozapine,haloperidol, risperidone
Dopamine agonists
Mebeverine, peppermint oil
Ephedrine, terbutaline
Table 2.
List of drugs associated with constipation [45].
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4.6 Medications associated with constipation
Many groups of drugs have been found to be strong correlated with constipa-
tion, highest for calcium channel blockers, and least for antiarrhythmics (Table 2).
5. Symptoms and signs of constipation
Constipation basically is a subjective condition. This is why the most important
tool for diagnosis of constipation mostly depends upon the clinical history. The
signs and symptoms common for both childhood and adult constipation are Irregu-
lar bowel activity with excessive foul-smelling flatulence and stools with irregular
texture. Sometimes patients may present with history of passage of small pellets or
less frequent large amount of stools and painful defecation. Withholding or
straining at stools, soiling or overflow. Abdominal distension or discomfort,
decreased appetite, easy fatigability, and irritable mood are few other symptoms.
6. Diagnosis and diagnostic approaches
Diagnosis mostly depends upon clinical history aided by radiological examina-
tion and blood examination to rule out underlying conditions: a thorough history
taking and physical examination can rule out most secondary causes of constipation.
6.1 Steps of evaluation
6.1.1 The clinical history and physical examination
Assessment of clinical criteria, presence of risk factors, and identification of
alarming features indicate the need for colonoscopy and/or radiological examina-
tion to rule out secondary causes [46, 47]. Digital rectal examination and procto-
logical examination may help to identify surgical causes of constipation. A careful
rectal examination should be performed in every patient with constipation and is
often the most revealing part of the clinical evaluation. A number of criteria have
been devised by different studies for the evaluation of constipation that have been
approved in the clinical practice which are as shown below.
6.1.1.1 Classic Lowa criteria
Pediatric constipation is defined whenever presence of at least two of the fol-
lowing criteria [48]:
• Two or more encopresis episodes per week
• Defecation frequency less than 3 times per week
• Periodic passage of very large amounts of stool once every 7–30 days (the
criterion of a large amount of stool is satisfied if it is estimated to be twice the
standard amount of stool, shown in a clay model, or if stools are so large that
they clog the toilet).
Solitary encopresis is defined in a child older than 4 years of age:
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• Two or more encopresis episodes per week
• Defecation frequency equal or more than 3 times per week
No passage of very large amounts of stool.
6.1.1.2 Paris consensus on childhood constipation terminology (PACCT criteria)
Chronic constipation is caused by the occurrence of two or more of the following
characteristics during the preceding 8 weeks [49]:
• Fewer than three bowel movements per week
• More than one episode of fecal incontinence per week
• Large stools in the rectum or palpable on abdominal examination
• Passage of large-diameter stools that may obstruct the toilet
• Display of retentive posturing and withholding behaviors
• Painful defecation
6.1.2 Investigations
Fecal, radiological, or endoscopic examinations are not routinely indicated in
case where severe symptoms are absent. Sigmoidoscopy is usually sufficient in
patients without severe symptoms and those under 50 years of age. Adults more
than 50 years of age are entitled to colonoscopy or both sigmoidoscopy and barium-
enema examination to rule out colorectal carcinoma.
6.1.3 Blood tests
Electrolyte imbalances, metabolic disorders, endocrine disorders, and parasito-
logical infestation can be can be ruled out by blood test. These examinations should
be ordered mainly in clinically suspicious cases.
6.1.4 Barium defecography
Barium defecography is an X-ray test where a thick paste containing barium is
placed into the rectum. It determines whether there are any abnormalities in the
pelvic floor. It is recommended to identify colorectal diseases (diverticular disease,
neoplasia, and megacolon).
6.1.5 Anorectal manometry
This test measures the pressure in anal canal when patient pushes during a bowel
movement. This test is recommended in cases refractory to medical treatment. The
main aim is to rule out diseases like aganglionosis and psychogenic megacolon. It
provides information about the rectoanal inhibitory reflex, the musculature tone of
the internal and external sphincters, and the rectal sensitivity, capacity, and com-
placency.
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6.1.6 Videodefecography, magnetic resonance defecography, or echodefecography
Videodefecography is the radiological study of evacuatory dynamics. It is useful in
the study of abnormalities such as rectocele, intussusception, enterocele,
sigmoidocele, anismus, and paradoxical contraction of the puborectalis muscle. Recent
literature suggest video defecography using only video recording without radiography
because of its high radiation exposure, whereas others have chosen magnetic reso-
nance defecography or echodefecography, without the use of ionizing radiation.
6.1.7 The colonic transit time (CTT) examination
A capsule containing radiopaque markers is swallowed and an abdominal radi-
ography is taken 5 days later. With this, the identification of three types of patterns
in patients can be done; in normal transit time, patients eliminate 80% of the
markers by the fifth day. In slow transit, more than 20% of the marker is retained
by the fifth day, distributed throughout the colon, and in those with bowel
obstruction, they retain more than 20% of the markers on the fifth day which
remains accumulated in the rectosigmoid region. Though it is a noninvasive test,
there is exposure to radiation even in low doses. CTT may be recommended to
assess the success of clinical or surgical treatment of chronic constipation.
6.1.8 Balloon expulsion test
A balloon filled with water (50–60 mL) is positioned in the rectal ampulla. If
expulsion is achieved by patient, pelvic floor dysfunction may be excluded. It has
been recommended by many constipation evaluation guidelines.
6.1.9 Electromyography of the anal sphincter (EMG)
Small electrical sensors are placed in the anal canal to record the electrical
activity of sphincter muscles during voluntary contraction, at rest, and with
coughing and evacuatory effort.
6.1.10 Hydrogen breath test
It is recommended for assessing the orocecal transit time. It aids to differentiate
dysmotility of the gastrointestinal tract (superior and inferior) from isolated colonic
inertia. It is recommended for serious and refractory cases of colonic inertia, prior
to the indication of a colectomy. Similarly a number of criteria have been devised by
different studies for the evaluation of constipation.
7. Management of constipation
7.1 Lifestyle modifications
Dehydration and decrease in physical activity are found to worsen so different
studies recommend adequate hydration and increase in physical activity [50].
High fiber diet is found to be beneficial for constipation. The ideal amount is
25–35 g per day. Fiber adds bulk to stools and makes bowel movements soft or firm.
To improve compliance with treatment, patients should be instructed to increase
their dietary fiber intake gradually to 20–25 g per day over a period of 1–2 weeks. If
this approach is not effective, commercially packaged fiber supplements should be
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tried. Regular bowel habits, careful use of laxatives, and control of medications
including dosage and timing are also effective for constipation.
7.2 Medications commonly used for constipation
7.2.1 Laxatives
7.2.1.1 Bulk laxative
The medications used for constipation are stated below in order [1].
Psyllium (Metamucil, Perdiem, and Fiberall)
• Natural fiber should be taken with plenty of water to avoid intestinal
obstruction; allergic reactions such as anaphylaxis and asthma are rare; titrate
up to 20 g.
Methylcellulose (Citrucel)
• Semisynthetic cellulose fiber that is relatively resistant to colonic bacterial
degradation; titrate up to 20 g
Polycarbophil (FiberCon, Equalactin, and Konsyl)
• Synthetic fiber of polymer of acrylic acid, resistant to bacterial degradation;
titrate up to 20 g
7.2.1.2 Osmotic laxative
This draws water into the intestines along osmotic gradient.
Magnesium hydroxide (Phillips’ Milk of Magnesia); 15–30 ml once or twice.
Magnesium citrate (Evac-Q-Mag); 150–300 ml as needed.
Sodium phosphate (Fleet Enema, Fleet Phospho-Soda, Visicol); 10–25 ml with 12 oz.
(360 ml) of water as needed.
7.2.1.3 Poorly absorbed sugar
Lactulose (Cephulac, Chronulac, and Duphalac);
Synthetic disaccharide; 15–30 ml once or twice a day.
7.2.1.4 Stimulant laxative
Stimulates intestinal motility or secretion.
Anthraquinones.
Cascara sagrada (Coleman, Sagrada-lax): 325 mg (or 5 ml) daily.
Senna (Senokot, Ex-Lax): 187 mg daily.
Castor oil (Purge, Neoloid, Emulsoil): 15–30 ml daily.
Bisacodyl (Dulcolax, Correctol): 5–10 mg every night.
Sodium picosulfate (Lubrilax, Sur-Lax): 5–15 mg every night.
7.2.1.5 Stool softener
Docusate sodium (Colace, Regulax SS, Surfak): 100 mg twice a day.
Mineral oil (Fleet Mineral Oil): 5–15 ml orally every night.
9
Constipation
DOI: http://dx.doi.org/10.5772/intechopen.82392
Phosphate enema (Fleet Enema): 120 ml daily.
Mineral oil retention enema (Fleet Mineral Oil Enema): 100 ml daily.
Tap-water enema: 500 ml daily.
Soapsuds enema: 1500 ml daily.
Glycerin bisacodyl suppository: 10 mg daily.
7.2.2 Cholinergic agent
Bethanechol (Urecholine): 10 mg daily.
7.2.3 Miscellaneous
Colchicine (Colsalide): 0.6 mg three times a day.
Misoprostol (Cytotec): 600–2400 μg daily.
7.2.4 Prokinetic agent
Tegaserod is a colonic prokinetic agent that improves stool consistency and
frequency in women with irritable bowel syndrome characterized by constipation.
5-HT4 receptor agonists* Cisapride (Propulsid): 10–20 mg four times a day.
Tegaserod (Zelnorm): 6 mg, twice a day.
7.2.5 Emerging drugs
Velusetrag and Naronapride (5-HT4 receptor agonists), Pumosetrag (5-HT3
receptor agonist) and few other drugs like plecanatide (colonic secretagogue),
methylnaltrexone (opioid receptor antagonist), elobixibat (prokinetic secreta-
gogue), and alvimopan (opioid receptor antagonist) are the few emerging drugs for
management of constipation [51].
7.3 Surgical management
Those patients who do not benefit from conservative treatment andwithout intesti-
nal obstructionmay profit from subtotal colectomywith ileorectal anastomosis. Refrac-
tory constipationmay have good results from total colonic resection and ileorectostomy
in a patient without defecatory disorder. A systematic review of 32 studies reported
satisfactory results post colectomy ranging between 39 and 100% of patients. Few
complications like diarrhea, incontinence, and intestinal obstructions were reported.
Similarly, in some studies, it was revealed that laparoscopic subtotal colectomywas
equally effective in those whowere suitable for colonic resection [52–54].
7.4 Miscellaneous
7.4.1 Biofeedback
This represents a behavioral treatment. Patients are trained regarding physio-
logical mechanisms of defecation. The use of their diaphragms and abdominal and
pelvic floor muscles for evacuation is emphasized. Sensory retraining is also given
[30]. Auditory or visual response, or both, on the functioning and coordination of
their anal sphincter and pelvic floor muscles is provided to patients. Balloon or
silicon-filled artificial stool, which is also termed as “freedom,” can be used as
biofeedback with more focus to normal coordination for successful defecation [1].
Educating the patients and a good rapport between the physician and the patients
are keys to successful biofeedback. Different studies on biofeedback treatment have
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reported an overall success rate of 67%. Nevertheless, adequate data regarding the
successful practice of biofeedback are still missing [55–57].
7.4.2 Abdominal massage
According to different studies, there is a positive influence of abdominal mas-
sage in constipation [58–60].
7.4.3 Botulinum type A toxin
Injection of botulinum type A toxin into the puborectalis muscle may be benefi-
cial in the treatment of defecatory disorders revealed by some studies. However,
no controlled trials have been done till date, so this method is not suggested [61].
8. Conclusions
Constipation is a very common problem worldwide that presents as a subtle dis-
ease yet can have relenting effects in a patient’s life. There are a number of preventable
risk factors, like food habit and personal habits, causing constipation; taking care of
them on time can play an important role in minimizing their effects which in turn
minimizes the socioeconomic burden of constipation significantly. Apart from that,
the early diagnosis and management of other underlying factors are important to give
relief to the patient from the undue physical and psychological stress.
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